We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

137 hedge funds and large institutions have $887M invested in Immunogen Inc in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more call options, than puts

Call options by funds: $9.27M | Put options by funds: $2.88M

7% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less funds holding

Funds holding: 142137 (-5)

22% less capital invested

Capital invested by funds: $1.14B → $887M (-$251M)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

Holders
137
Holders Change
-5
Holders Change %
-3.52%
% of All Funds
3.94%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
17
Increased
46
Reduced
43
Closed
22
Calls
$9.27M
Puts
$2.88M
Net Calls
+$6.38M
Net Calls Change
+$2.93M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
51
State Board of Administration of Florida Retirement System
Florida
$1.06M +$40.2K +3,204 +4%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$1.06M -$133K -10,605 -11%
LK
53
Lumbard & Kellner
New Hampshire
$955K -$8.79K -700 -0.9%
Goldman Sachs
54
Goldman Sachs
New York
$926K +$21.6K +1,722 +2%
American Century Companies
55
American Century Companies
Missouri
$900K +$293K +23,304 +44%
NG
56
NatWest Group
United Kingdom
$879K +$66.5K +5,298 +8%
Natixis Advisors
57
Natixis Advisors
Massachusetts
$848K +$81K +6,456 +10%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$822K
HCM
59
Highbridge Capital Management
New York
$761K +$806K +64,190 New
AIG
60
American International Group
New York
$741K -$16.9K -1,346 -2%
PPA
61
Parametric Portfolio Associates
Washington
$720K +$74.2K +5,912 +11%
PAM
62
Paradigm Asset Management
New York
$685K +$52.7K +4,200 +8%
U
63
UBS
Switzerland
$666K -$10.7K -852 -1%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$659K -$109K -8,697 -14%
PG
65
PEAK6 Group
Illinois
$622K +$374K +29,808 +131%
DADC
66
D.A. Davidson & Co
Montana
$608K +$196K +15,649 +44%
BA
67
BlackRock Advisors
Delaware
$607K -$251K -19,959 -28%
DekaBank Deutsche Girozentrale
68
DekaBank Deutsche Girozentrale
Germany
$583K -$41.4K -3,300 -6%
BG
69
BlackRock Group
United Kingdom
$575K -$282K -22,484 -32%
Citigroup
70
Citigroup
New York
$575K -$50.3K -4,006 -8%
VOYA Investment Management
71
VOYA Investment Management
Georgia
$565K
SCM
72
Stonebridge Capital Management
California
$556K +$261K +20,810 +80%
Allianz Asset Management
73
Allianz Asset Management
Germany
$545K +$113K +9,000 +24%
TC
74
TFS Capital
Pennsylvania
$534K +$566K +45,077 New
Bank of America
75
Bank of America
North Carolina
$440K +$359K +28,576 +337%

IMGN Hedge Fund Activity: Q2 2014 in Review

137 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2014, worth a combined $887M — down 22% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of IMGN and 17 opened new positions — a net loss of 5 holders — while 43 trimmed existing stakes and 46 added.

The largest buyer was ClearBridge Investments, adding an estimated $8.56M. The largest seller was Wellington Management Group, cutting an estimated $22.8M.

  • 137 institutional investors held Immunogen Inc (IMGN) as of Q2 2014, down from 142 in Q1 2014.
  • Funds reported $887M of Immunogen Inc stock for Q2 2014, down 22% quarter-over-quarter.
  • 17 funds opened new Immunogen Inc positions in Q2 2014 and 22 closed out, a net change of -5 holders.
  • The largest Immunogen Inc buyer in Q2 2014 was ClearBridge Investments, an estimated $8.56M added.
  • The largest Immunogen Inc seller in Q2 2014 was Wellington Management Group, an estimated $22.8M sold.

Based on aggregated 13F filings for Q2 2014.